Eltrombopag improves refractory thrombocytopenia in patients with Sjögren's syndrome

INTRODUCTION: Eltrombopag, a kind of thrombopoietin (TPO) receptor agonist, plays the role on the megakaryocyte to activate the platelet production and rapidly increase the number of circulating platelets in patients with primary immune thrombocytopenia (ITP). Eltrombopag provides an opportunity for...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Liping, Zhang, Yan, Lin, Na, Song, Xinwei, Dai, Qiaoding
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10306133/
https://www.ncbi.nlm.nih.gov/pubmed/35603866
http://dx.doi.org/10.1177/00368504221102786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10306133/
https://www.ncbi.nlm.nih.gov/pubmed/35603866
http://dx.doi.org/10.1177/00368504221102786

Ejemplares similares